|
Volumn 41, Issue 3, 2001, Pages 257-263
|
Differentiating the efficacy of 5-HT1B/1D agonists
|
Author keywords
5 HT1B 1D agonists; Clinical trials; Efficacy; Meta analysis; Migraine
|
Indexed keywords
NARATRIPTAN;
PLACEBO;
RIZATRIPTAN;
SEROTONIN 1B AGONIST;
SEROTONIN 1D AGONIST;
SUMATRIPTAN;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISABILITY;
DRUG EFFICACY;
DRUG RESPONSE;
HUMAN;
META ANALYSIS;
MIGRAINE;
NONLINEAR SYSTEM;
PAIN ASSESSMENT;
PATIENT SELECTION;
PRIORITY JOURNAL;
ACUTE DISEASE;
CONTROLLED CLINICAL TRIALS;
HUMANS;
META-ANALYSIS;
MIGRAINE DISORDERS;
PLACEBOS;
RESEARCH DESIGN;
SENSITIVITY AND SPECIFICITY;
SEROTONIN AGONISTS;
VARIATION (GENETICS);
|
EID: 0035079047
PISSN: 00178748
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1526-4610.2001.111006257.x Document Type: Article |
Times cited : (9)
|
References (6)
|